791L-Target-Bismuth Subsalicylate 525 mg / 30 mL Oral Suspension
- Manufacturer
- TARGET CORPORATION | TIME CAP LABORATORIES, INC. | MARKSANS PHARMA LIMITED
- Effective date
- 2025-04-12
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-01 01:03:08
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
Drug Facts
Drug Facts
OTC - ACTIVE INGREDIENT SECTION
Active ingredient
(in each 30 mL dose)
Bismuth subsalicylate 525 mg
OTC - PURPOSE SECTION
Purpose
Upset stomach reliever and antidiarrheal
INDICATIONS & USAGE SECTION
Uses relieves
■ travelers’ diarrhea
■ diarrhea
■ upset stomach due to overindulgence in food and drink, including: ■ heartburn ■ indigestion ■ nausea ■ gas ■ belching ■ fullness
WARNINGS SECTION
Warnings
Reye’s syndrome: Children and teenagers who have or are recovering
from chicken pox or flu-like symptoms should not use this product. When
using this product, if changes in behavior with nausea and vomiting occur,
consult a doctor because these symptoms could be an early sign of Reye’s
syndrome, a rare but serious illness.
Allergy alert: Contains salicylate. Do not take if you are
■ allergic to salicylates (including aspirin)
■ taking other salicylate products
OTC - DO NOT USE SECTION
Do not use if you have
■ an ulcer ■ a bleeding problem ■ bloody or black stool
OTC - ASK DOCTOR SECTION
Ask a doctor before use if you have ■ fever ■ mucus in the stool
OTC - ASK DOCTOR/PHARMACIST SECTION
Ask a doctor or pharmacist before use if you are taking any drug for
■ anticoagulation (thinning the blood) ■ diabetes ■ gout ■ arthritis
OTC - WHEN USING SECTION
When using this product a temporary, but harmless, darkening of the stool and/or tongue may occur
OTC - STOP USE SECTION
Stop use and ask a doctor if
■ symptoms get worse or last more than 2 days
■ ringing in the ears or loss of hearing occurs
■ diarrhea lasts more than 2 days
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
DOSAGE & ADMINISTRATION SECTION
Directions
■ shake well before use
■ only use dose cup provided
■ adults and children 12 years and over:
- 30 mL (1 dose) every ½ hour or 60 mL (2 doses) every hour as needed for diarrhea/traveler's diarrhea
- 30 mL (1 dose) every ½ hour as needed for overindulgence (upset stomach, heartburn, indigestion, nausea)
■ do not exceed 8 doses (240 mL) in 24 hours
■ use until diarrhea stops but not more than 2 days
■ children under 12 years: ask a doctor
■ drink plenty of clear fluids to help prevent dehydration caused by diarrhea
OTHER SAFETY INFORMATION
Other information
■ each 30 mL dose contains:
salicylate 199 mg
■ keep tightly closed ■ protect from freezing
■ avoid excessive heat (over 104°F or 40°C)
INACTIVE INGREDIENT SECTION
Inactive ingredients benzoic acid, D&C red no. 22, D&C red no. 28, flavor, glycerin, purified water, sucralose, xanthan gum
OTC - QUESTIONS SECTION
Questions or comments? Call 1-800-910-6874
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 308762 | bismuth subsalicylate 525 MG in 30 mL Oral Suspension | PSN | 2 |
| 308762 | bismuth subsalicylate 17.5 MG/ML Oral Suspension | SCD | 2 |
| 308762 | bismuth subsalicylate 1.75 % Oral Suspension | SY | 2 |
| 308762 | bismuth subsalicylate 262 MG per 15 ML Oral Suspension | SY | 2 |
| 308762 | bismuth subsalicylate 524 MG per 30 ML Oral Suspension | SY | 2 |
| 308762 | bismuth subsalicylate 525 MG per 30 ML Oral Suspension | SY | 2 |
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| BISMUTH CATION Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0be8e4ae-4d57-49f3-b3a9-e4728b4e8d15 | Product name | 1 | 20240313 |
| c6f86816-7da6-43ea-8c25-ac9758311cc5 | Product name | 1 | 20220118 |
| dea2eded-d1e7-46bb-9a3d-f8dc20de6277 | Product name | 1 | 20190408 |
| 252e11b6-1a9a-4283-a242-df2c129c496d | Product name | 3 | 20170717 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11673-291-06 | 5-Symptom Digestive Relief | 236 mL in 1 BOTTLE, PLASTIC | SUSPENSION | 236 | 2 | |
| 11673-291-07 | 5-Symptom Digestive Relief | 473 mL in 1 BOTTLE, PLASTIC | SUSPENSION | 473 | 2 | |
| 11673-291-08 | 5-Symptom Digestive Relief | 2 in 1 PACKAGE | SUSPENSION | 2 | 2 |
Products#
Every source-derived product name is available through these pages.
- 5-Symptom Digestive Relief
- Bismuth Subsalicylate
- XANTHAN GUM
- D&C RED NO. 22
- WATER
- D&C RED NO. 28
- SUCRALOSE
- SALICYLIC ACID
- BISMUTH CATION
- GLYCERIN
- BENZOIC ACID
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 11673-291 | 11673-291-06, 11673-291-07, 11673-291-08 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| XANTHAN GUM | TTV12P4NEE | IACT |
| D&C RED NO. 22 | 1678RKX8RT | IACT |
| WATER | 059QF0KO0R | IACT |
| D&C RED NO. 28 | 767IP0Y5NH | IACT |
| SUCRALOSE | 96K6UQ3ZD4 | IACT |
| BISMUTH SUBSALICYLATE | 62TEY51RR1 | ACTIB |
| GLYCERIN | PDC6A3C0OX | IACT |
| BENZOIC ACID | 8SKN0B0MIM | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 5-Symptom Digestive Relief | BISMUTH SUBSALICYLATE | TARGET CORPORATION | 28fba615-48ca-8d96-e063-6394a90a2797 | 2025-04-12 | Warnings | 11673-291-08 11673-291-07 11673-291-06 11673-291 11673029106 11673029107 11673029108 32932e3f-edb6-5d92-e063-6394a90a4c43 28fba615-48ca-8d96-e063-6394a90a2797 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.



